Risorse esterne
Opinione della community
Prezzo Variazione Volume
1.14 +7.55 €
P/E Obiettivo ad 1anno
0 1.12 €

Compra - Vendi

Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Altri utenti che hanno investito

Transations in last week
Buy: 6
Sell : 4

Gian Marco



Sizling Stock Update: Galectin Therapeutics, Inc. (NASDAQ:GALT) - FactsReporter

Insider Trades for Galectin Therapeutics, Inc. show that the latest trade was made on 9 Nov 2016 where 10X Fund, L.P., the Beneficial Owner of More than 10% Class completed a transaction type “Sell” in which 17096 shares were traded at a price of $0.78. Leggi

Healthcare Stocks Highlighted As Major Movers: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Galectin ... - TWN

Galectin Therapeutics, Inc. (GALT) opened the session with a $1.07 price tag, later ranging from $1.07 to $1.18, the range at which the stock has traded at throughout the day. The stock stands nearly $1.98 off versus the 52-week high of $3.05 and $0.58 ...altro » Leggi

Galectin Therapeutics Inc. (GALT) Upgraded by Zacks Investment Research to "Buy" - Sports Perspectives

Galectin Therapeutics logo Galectin Therapeutics Inc. (NASDAQ:GALT) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Tuesday. The brokerage presently has a $1.25 target price on the stock ... Leggi

These Brokerage Research Findings Are Noteworthy: Galectin ... - Review Fortune

Galectin Therapeutics, Inc. (NASDAQ:GALT) showed a growth of 7.55% from the market's prior closing price. That gain sent the price at $1.14 per share as of ...altro » Leggi

Stocks to Concentrate: Endo International plc (NASDAQ:ENDP) , Galectin Therapeutics Inc. (NASDAQ:GALT) - WsNews 4investors

Endo International plc (NASDAQ:ENDP) and showed negative change of +0.00% while the stock's final trade was registered at $ 13.19. However, its previous closing price was seen at $13.19. The stock negotiated total number of 0 shares as compared to 3 ...altro » Leggi

Markets End Mostly Higher, How Did This Stock Fare: Galectin Therapeutics, Inc. (NASDAQ:GALT) - Wall Street Beacon

Galectin Therapeutics, Inc. (NASDAQ:GALT) performed nicely this week, continuing its impressive near-term upward movement. The stock has moved north 8.57% over the past week of trading. Looking further out, over the past twelve months, Galectin ...altro » Leggi

GALECTIN THERAPEUTICS INC. (NASDAQ:GALT) Files An 8-K Entry into a Material Definitive Agreement - Market Exclusive

Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease and cancer. The Company's drug candidates are based on its method of targeting galectin proteins, ... Leggi

Galectin Therapeutics Inc. (GALT) Lifted to Buy at Zacks Investment Research - The Cerbat Gem

Galectin Therapeutics (NASDAQ:GALT) traded up 5.9717% during midday trading on Tuesday, reaching $1.1233. 1,030,277 shares of the company's stock were exchanged. Galectin Therapeutics has a 1-year low of $0.49 and a 1-year high of $3.05. Leggi

Successful Option Trading: Galectin Therapeutics Inc (NASDAQ:GALT) Winning Short Put Spreads Can Outperform ... - CML News

There is a lot less 'luck' involved in successful option trading than many people have come to understand. We can get specific with short put spreads on GALT in this dossier. Let's look at a two-year back-test of a short put spread strategy and use the ...altro » Leggi

Street Session Update on Galectin Therapeutics Inc. (NASDAQ:GALT) - Liberty News

Let's take a quick look at where covering equity analysts see Galectin Therapeutics Inc. (NASDAQ:GALT) going in the future. Analysts polled by Thomson Reuters have a current consensus target on company stock of $1.12. It is important to mention that ...altro » Leggi